Valley Cottage, NY, Jan. 30, 2018 -- Several drugs are easily available over the counter, and a number of people using illicit drugs is very high especially in low income countries. A new research report by Future Market Insights titled ‘Drugs of Abuse Testing Market: Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027’ provides the complete scenario of the drugs of abuse testing market worldwide. The report depicts the drug abuse market as well as the drug abuse testing market in different regions and the factors impacting market growth. This study further highlights different segments of the market such as the drug class, technique type and end users. According to the research report, the global drugs of abuse testing market is expected to reach a market value of over US$ 2,200 Mn by the end of 2027. The market is expected to grow at a CAGR of 6.1% during the forecast period. Revenue growth of the global market is helped by a rise in the test rates and technological advancements in drug abuse testing. Companies are now focussing on new launches and reducing the costs of drugs of abuse testing drugs in order to gain maximum market share.
Global Drugs of Abuse Testing Market: Dynamics
The growth of the drugs of abuse testing market is driven by various factors such as a rise in the number of clinical labs and a growing abuse of clinical drugs. Governments throughout the world have also increased expenditure on law enforcement agencies aimed towards drug interdiction through mandatory screening of potential illicit drug abusers. This has helped boost revenue growth of the drugs of abuse testing market.
Drugs of Abuse Testing Market Segmentation Drug Type – Psychostimulants, Narcotic, Hallucinogens, Sedatives, Others; Technique Type – Immunoassay, Chromatography, Rapid Testing; End User – Hospitals, Diagnostics Laboratories, Forensic Laboratories, Others: https://www.futuremarketinsights.com/reports/drug-of-abuse-testing-market
However, the emerging countries in Asia, Latin America and Africa have lower awareness of drugs of abuse testing and have lesser social support to decrease the consumption of illicit drugs. These regions even face a lack of government initiatives. This may lead to a downfall in the overall drugs of abuse testing market.
Request to View Sample Report - https://www.futuremarketinsights.com/reports/sample/rep-gb-1649
Global Drugs of Abuse Testing Market: Segmental Analysis
On the basis of region, Asia Pacific dominates the global drugs of abuse testing market in terms of growth rate with a 7.0% CAGR during the forecast period. However North America holds the maximum market share with an estimated valuation of US$ 620 Mn by the end of 2027.
On the basis of drug type, Sedatives is the fastest growing segment. Hallucinogens are expected to hold the maximum market share during the forecast period.
On the basis of technique type, Immunoassay dominates the market with the maximum market size of over US$ 870 Mn estimated by the end of 2027. The rapid testing segment is expected to grow at the fastest rate.
Based on end users, forensic laboratories are expected to hold the highest market share by the end of 2027, whereas diagnostic laboratories are predicted to witness the highest growth rate of 6.8% during the forecast period..
Request Report TOC @ https://www.futuremarketinsights.com/askus/rep-gb-1649
Global Drugs of Abuse Testing Market: Competitive Landscape
This comprehensive research report includes detailed profiles of all the major players in the global market. Some of the top companies mentioned in the report include Quest Diagnostics, F.Hoffmann La-Roche Ltd, Siemens Healthineers (Siemens AG), Thermo Fisher Scientific, Inc., Alere, Inc. (Sub. Abbott Laboratories), Shimadzu Corporation, Laboratory Corporation of America Holdings, Drägerwerk AG & Co. KGaA, and Express Diagnostics International Inc..
Global Drugs of Abuse Testing Market is available @ US$ 5000
About FMI
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.
Mr. Sudip Saha Future Market Insights 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 F: +1-845-579-5705 T (UK): + 44 (0) 20 7692 8790 Sales: [email protected] Press Office: [email protected] FMI Blog: http://www.fmiblog.com/ Website: www.futuremarketinsights.com


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



